European Medicines Agency, Amsterdam, the Netherlands
The Committee for Advanced Therapies (CAT) is the committee that is responsible for assessing the quality, safety and efficacy of advanced-therapy medicines.
CAT monthly report of application procedures, guidelines and related documents on advanced therapies: September 2014 meeting
Reference Number: EMA/CAT/581538/2014Summary:
The CAT Monthly Report includes statistical data on CAT scientific recommendations on Advanced Therapy Medicinal Product (ATMP) classification, certifications, initial evaluations, CAT contributions to Scientific Advice and Paediatric Investigation Plans, as well as variations, line extensions, renewals.